The two vaccines are the same. The original solution is produced by Beijing Sinovac Zhongwei and is packaged by Dalian (Sinovac).
Related introduction:
Beijing Sinovac Zhongwei Biotechnology Co., Ltd. is a high-tech biotech enterprise located in Beijing, China under Sinovac Holdings. It was registered and established in 2009 and is located in Beijing. Building 1, No. 21, Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District.
Beijing Sinovac Zhongwei Biotechnology Co., Ltd. is engaged in the research, development, production and technical services of human vaccines and related products, providing technical support for the prevention and control of major infectious diseases.
The company has undertaken 2 major national new drug creation projects, 2 Beijing Science and Technology Plans, and has obtained 14 Chinese invention patent authorizations. Many research results have been published in internationally renowned publications such as Science, Nature, and Lancet Infect Diseases. Academic journals.
On February 5, 2021, the State Food and Drug Administration approved in accordance with the law the new coronavirus inactivated vaccine Kelifu developed by Beijing Sinovac Zhongwei Biotechnology Co., Ltd. for domestic marketing with conditions.